Initial to indicate certification as to information on this page

(full text of certification is on page one).

Date

INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. 

Use additional sheet(s) if necessary.

2. Case # and Name 3. Date and Type of DCI and Number

4. EPA Product 

Registration

5. I wish to cancel 

this product 

registration 

voluntarily

6. Generic Data 7. Product Specific Data

6a. I am claiming a Generic Data 

Exemption because I obtain the 

active ingredient from the source 

EPA registration number listed 

below.

6b. I agree to satisfy Generic Data

Requirements as indicated on the 

attached form entitled 

"Requirements Status and 

Registrant's Response."

7a. My product is an MUP and I 

agree to satisfy the MUP 

requirement on the attached form

entitled "Requirements Status and

Registrant's Response."

7b. My product is an EUP and I 

agree to satisfy the EUP 

requirement on the attached form 

entitled "Requirements Status and 

Registrant's Response."

OMB Approval 2070-0174

1. Company Name and Address

 

0040 - Chloropicrin

Chemical # and Name: 081501

Chloropicrin

15-May-2012

GENERIC

ID # GDCI-081501-1155

United States Environmental Protection Agency

Washington, D.C. 20460

DATA CALL-IN RESPONSE

Page of 1 1

8. Certification: I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any

knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.

Signature and Title of Company's Authorized Representative ______________________________________________________

10. Name of Company

N/A N/A

9. Date

11. Phone Number 
Initial to indicate certification as to information on this page (full text of certification is on page one) Date

13. Phone Number

10. Certification: I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any 

knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.

12. Name of Company

11. Date

OMB Approval 2070-0174

United States Environmental Protection Agency 

Washington, D.C. 20460

REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE

INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary.

4. Guideline

Requirement

Number

5. Study Title Progress 

Reports

1 2 3

6. Use 

Pattern

7. Test 

Substance

8. Time

Frame 

(Months)

9. Registrant

Response

P

R

O

T

O

C

O

L

1. Company Name and Address 2. Case # and Name 3. Date and Type of DCI and Number

Signature and Title of Company's Authorized Representative _________________________________________________________________

 

SS-1076 Ambient Air Monitoring

0040 - Chloropicrin

Chemical # and Name: 081501

Chloropicrin

15-May-2012

GENERIC

ID # GDCI-081501-1155

C EP; PAI; TGAI 36

Page 1 of 

(1, 2, 3, 4, 5, 

6)

Y

1
United States Environmental Protection Agency 

Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

0040 - Chloropicrin

GDCI-081501-1155

1

2

3

4

5

6

Key: Residue of Concern = Residue of Concern; TEP = Typical End Use Product [TEP]; TGAI = Technical Grade Active Ingredient [TGAI]; TGAI/PAIRA = Technical Grade of the Active Ingredient or Pure Active 

Ingredient, Radio Labelled; TGAI, TEP = Technical Grade of the Active Ingredient or Technical End-Use Product; TGAI/PAI = Technical Grade Active Ingredient, Pure Active Ingredient

The sampling design of the study must focus on community level exposures in a longitudinal fashion (i.e., repeated observations of the same variable over a period of time). Monitoring samples 

are to be collected at least twice per week during the chloropicrin pesticide product use season in the particular locale being monitored, and once per week during the season when chloropicrin

pesticide products are not being used in the particular locale being monitored, for a period of two consecutive years.

Submit a draft protocol, which includes a detailed study implementation timeline, to the Agency within 120 days of receipt of this DCI. The Agency must review and approve the protocol prior to 

study initiation.

EPA encourages the registrants to work with existing ambient air monitoring programs such as in CA and WA or the registrants may develop their own program.

Criteria that must be considered in selecting the monitoring sites include: (1) Areas of highest chloropicrin use; (2) Duration of the season of chloropicrin use for a candidate study area; (3) 

Geographically unique features that could affect ambient concentration levels (e.g., valleys, flat terrain); (4) Weather considerations which may adversely impact ambient exposures, e.g., 

frequent inversions or air stagnation events; (5) Proximity of chloropicrin use to bystander populations; (6) Proximity of chloropicrin use to sensitive populations (e.g., school children); (7) 

Proximity of chloropicrin use to minority populations to define potential environmental justice concerns such as disparate exposures to certain populations; and (8) Logistical access.

Ambient air monitoring for chloropicrin must be conducted in at least three chloropicrin high use areas. The registrant must propose study sites in the protocol based on current chloropicrin 

usage data. See EPA's memo, Process for Defining High-Use Fumigation Areas at the State and County Levels, for guidance on how to determine high use areas: 

http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2007-0350-0405.

A yearly progress report must be submitted to the Agency once the protocol has been approved, i.e. 12 months after the protocol is approved and annually thereafter. The report must: (1) 

Report on and demonstrate progress according to the timeline described in the approved protocol for implementation: (2) Identify and describe any protocol amendments or deviations; (3) 

Identify and describe any implementation issues (e.g., logistical or access issues); and (4) Report and summarize all preliminary findings to date, or in the case of subsequent annual progress 

reports, all preliminary findings since the last annual report.

Case # and Name:

DCI Number:

Page: 1 of 1

Footnotes: The following footnotes are referenced in column two (5. Study Title) of the Requirements Status and Registrant's Response form. 

These footnotes apply in addition to any test notes included in 40 CFR Part 158 with respect to the particular data requirement.

Use Categories Key:

C - Terrestrial nonfood crop
United States Environmental Protection Agency 

Washington, D.C. 20460

LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICE

Case # and Name: 0040 - Chloropicrin

Page: 1 of 1

62341

7747

5785

62531

66330

TRINITY MANUFACTURING, INC

NIKLOR CHEMICAL CO., INC.

GREAT LAKES CHEMICAL CORPORATION

ASHTA CHEMICALS, INC.

ARYSTA LIFESCIENCE NORTH AMERICA, 

LLC 

Co. Nr. Company Name Agent For Company

EDWARD W. LYLE

CHEMTURA CORPORATION

1805 45TH ST., N.W.

1667 PURDY AVE.

1801 HIGHWAY 52 WEST

3509 MIDDLE ROAD, P.O. Box 858

15401 WESTON PARKWAY, SUITE 150

Address City ZIP

WASHINGTON

MOJAVE

WEST LAFAYETTE

ASHTABULA

CARY

200072070

93501 

47906 

440050858

27513 

OMB Approval 2070-0174

State

DC

CA

IN

OH

NC

 DCI Number: GDCI-081501-1155
LINKS TO FORMS:

The pesticide registration forms that are listed below can be found at:

http://www.epa.gov/opprd001/forms/

Link to Confidential Statement of Formula and Instructions (Form # 8570-4)

http://www.epa.gov/opprd001/forms/8570-4.pdf

Certification of Attempt to Enter Into an Agreement With Registrants for 

Development of Data (Form # 8570-32)

http://www.epa.gov/opprd001/forms/8570-32.pdf

Certification With Respect to Citation of Data (Form # 8570-34)

http://www.epa.gov/opprd001/forms/8570-34.pdf